NCT01467024View on ClinicalTrials.gov

Evaluation of the MP Diagnostics HTLV Blot 2.4

UnknownOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

June 30, 2012

Conditions
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1Human T-lymphotropic Virus 2HTLV I Associated T Cell Leukemia LymphomaHTLV I Associated Myelopathies
Interventions
OTHER

CDPHL Algorithm

Supplemental testing algorithm performed by the CDPHL.

Trial Locations (2)

38611

LABS, Inc, St Louis

94804

California Department of Public Health, Richmond

Sponsors
All Listed Sponsors
collaborator

Vital Systems Inc.

OTHER

lead

MP Biomedicals, LLC

INDUSTRY